xG/xG+ hereditary cancer germline tests powered by Ambry Genetics, and xM/xM (NeXT Personal Dx) minimal residual disease and monitoring tests. They also will have access to AI-enabled, algorithmic, ...
Report Ocean has published a new report on the Companion Diagnostics for Oncology Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The ...